Antinatriuretic effect of vasopressin in humans is amiloride sensitive, thus ENaC dependent

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 4, 2011, Pages 753-759

  Blanchard, Anne ^a,b,c   Frank, Michael ^a,b,d   Wuerzner, Grégoire ^a,b,c   Peyrard, Severine ^b   Bankir, Lise ^e   Jeunemaitre, Xavier ^a,b,d   Azizi, Michel ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c INSERM   (France)

^d PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^e CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 DESAMINO 8 DEXTRO ARGININE VASOPRESSIN; ALDOSTERONE; AMILORIDE; CREATININE; EPITHELIAL SODIUM CHANNEL; POTASSIUM; SODIUM; UNCLASSIFIED DRUG; VASOPRESSIN;

ADULT; ALDOSTERONE RELEASE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIET; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OSMOLALITY; PLASMA OSMOLALITY; POTASSIUM BLOOD LEVEL; POTASSIUM EXCRETION; POTASSIUM URINE LEVEL; SODIUM BLOOD LEVEL; SODIUM EXCRETION; SODIUM URINE LEVEL; URINALYSIS; URINE FLOW RATE;

ADULT; AMILORIDE; DEAMINO ARGININE VASOPRESSIN; EPITHELIAL SODIUM CHANNEL; HUMANS; MALE; NATRIURETIC AGENTS; POTASSIUM, DIETARY; RECEPTORS, VASOPRESSIN; SODIUM; SODIUM, DIETARY;

EID: 79955567459     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06540810     Document Type: Article

References (34)

1. Nielsen S, Kwon TH, Christensen BM, Promeneur D, Frokiaer J, Marples D: Physiology and pathophysiology of renal aqua-porins. J Am Soc Nephrol 10: 647-663, 1999
2. Fenton RA, Knepper MA: Urea and renal function in the 21st century: Insights from knockout mice. J Am Soc Nephrol 18: 679-688, 2007
3. Balment RJ, Brimble MJ, Forsling ML, Musabayane CT: Natriuretic response of the rat to plasma concentrations of argi-nine vasopressin within the physiological range. J Physiol 352: 517-526, 1984
4. Leaf A, Bartter FC, Santos RF, Wrong O: Evidence in man that urinary electrolyte loss induced by pitressin is a function of water retention. J Clin Invest 32: 868-878, 1953
5. Anastasio P, Cirillo M, Spitali L, Frangiosa A, Pollastro RM, De Santo NG: Level of hydration and renal function in healthy humans. Kidney Int 60: 748-756, 2001
6. Perucca J, Bichet DG, Bardoux P, Bouby N, Bankir L: Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists. J Am Soc Nephrol 19: 1721-1731, 2008
7. Bankir L, Fernandes S, Bardoux P, Bouby N, Bichet DG: Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans. J Am Soc Nephrol 16: 1920-1928, 2005
8. Tomita K, Pisano JJ, Knepper MA: Control of sodium and potassium transport in the cortical collecting duct of the rat. Effects of bradykinin, vasopressin, and deoxycorticosterone. J Clin Invest 76: 132-136, 1985
9. Nicco C, Wittner M, DiStefano A, Jounier S, Bankir L, Bouby N: Chronic exposure to vasopressin upregulates ENaC and sodium transport in the rat renal collecting duct and lung. Hypertension 38: 1143-1149, 2001
10. Morris RG, Schafer JA: cAMP increases density of ENaC sub-units in the apical membrane of MDCK cells in direct proportion to amiloride-sensitive Na(+) transport. J Gen Physiol 120: 71-85, 2002
11. Schafer JA: Abnormal regulation of ENaC: Syndromes of salt retention and salt wasting by the collecting duct. Am J Physiol Renal Physiol 283: F221-F235, 2002
12. Sauter D, Fernandes S, Goncalves-Mendes N, Boulkroun S, Bankir L, Loffing J, Bouby N: Long-term effects of vasopressin on the subcellular localization of ENaC in the renal collecting system. Kidney Int 69: 1024-1032, 2006
13. Boulkroun S, Ruffieux-Daidie D, Vitagliano JJ, Poirot O, Charles RP, Lagnaz D, Firsov D, Kellenberger S, Staub O: Vasopressin-inducible ubiquitin-specific protease 10 increases ENaC cell surface expression by deubiquitylating and stabilizing sorting nexin 3. Am J Physiol Renal Physiol 295: F889-F900, 2008
14. Bugaj V, Pochynyuk O, Stockand JD: Activation of the epithelial Na+ channel in the collecting duct by vasopressin contributes to water reabsorption. Am J Physiol Renal Physiol 297: F1411-F1418, 2009
15. Azizi M, Iturrioz X, Blanchard A, Peyrard S, De Mota N, Chartrel N, Vaudry H, Corvol P, Llorens-Cortes C: Reciproca regulation of plasma apelin and vasopressin by osmotic stimuli. J Am Soc Nephrol 19: 1015-1024, 2008
16. Ethier JH, Kamel KS, Magner PO, Lemann J Jr., Halperin ML: The transtubular potassium concentration in patients with hypokalemia and hyperkalemia. Am J Kidney Dis 15: 309-315, 1990
17. Murdoch DL, Forrest G, Davies DL, McInnes GT: A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects. Br J Clin Pharmacol 35: 373-378, 1993
18. Agnoli GC, Borgatti R, Cacciari M, Lenzi P, Marinelli M, Stipo L: Low-dose desmopressin infusion: Renal action in healthy women in moderate salt retention and depletion, and interactions with prostanoids. Prostaglandins Leukot Essent Fatty Acids 67: 263-273, 2002
19. Capasso G, Saviano C, Ciani F, Lang F, Russo F, De Santo NG: A decrease in renal medullary tonicity stimulates anion transport in Henle's loop of rat kidneys. Am J Physiol 274: F693-F699, 1998
20. De Wardener HE, Herxheimer A: The effect of a high water intake on the kidney's ability to concentrate the urine in man. 1957. J Am Soc Nephrol 11: 980-987, 2000
21. Gottschalk CW: Osmotic concentration and dilution of the urine. Am J Med 36: 670-685, 1964
22. Bouby N, Ahloulay M, Nsegbe E, Dechaux M, Schmitt F, Bankir L: Vasopressin increases glomerular filtration rate in conscious rats through its antidiuretic action. J Am Soc Neph-rol 7: 842-851, 1996
23. Andersen LJ, Andersen JL, Schutten HJ, Warberg J, Bie P: An-tidiuretic effect of subnormal levels of arginine vasopressin in normal humans. Am J Physiol 259: R53-R60, 1990
24. Humphreys MH, Friedler RM, Earley LE: Natriuresis produced by vasopressin or hemorrhage during water diuresis in the dog. Am J Physiol 219: 658-665, 1970
25. Kompanowska-Jezierska E, Emmeluth C, Grove L, Christensen P, Sadowski J, Bie P: Mechanism of vasopressin natriuresis in the dog: Role of vasopressin receptors and prostaglandins. Am J Physiol 274: R1619-R1625, 1998
26. Butterworth MB, Edinger RS, Frizzell RA, Johnson JP: Regulation of the epithelial sodium channel by membrane trafficking. Am J Physiol Renal Physiol 296: F10-F24, 2009
27. Bankir L, Bichet DG, Bouby N: Vasopressin V2 Receptors, ENaC and sodium reabsorption: A risk factor for hypertension? Am J Physiol Renal Physiol 299: F917-F28, 2010
28. Loffing J, Zecevic M, Feraille E, Kaissling B, Asher C, Rossier BC, Firestone GL, Pearce D, Verrey F: Aldosterone induces rapid apical translocation of ENaC in early portion of renal collecting system: Possible role of SGK. Am J Physiol Renal Physiol 280: F675-F682, 2001
29. Gimenez I, Forbush B: Short-term stimulation of the renal Na-K-Cl cotransporter (NKCC2) by vasopressin involves phos-phorylation and membrane translocation of the protein. J Biol Chem 278: 26946-26951, 2003
30. Ecelbarger CA, Kim GH, Wade JB, Knepper MA: Regulation of the abundance of renal sodium transporters and channels by vasopressin. Exp Neurol 171: 227-234, 2001
31. Chabardes D, Gagnan-Brunette M, Imbert-Teboul M, Gontcharevskaia O, Montegut M, Clique A, Morel F: Adenyl-ate cyclase responsiveness to hormones in various portions of the human nephron. J Clin Invest 65: 439-448, 1980
32. Ruggles BT, Murayama N, Werness JL, Gapstur SM, Bentley MD, Dousa TP: The vasopressin-sensitive adenylate cyclase in collecting tubules and in thick ascending limb of Henle's loop of human and canine kidney. J Clin Endocrinol Metab 60: 914-921, 1985
33. Mutig K, Paliege A, Kahl T, Jons T, Muller-Esterl W, Bach-mann S: Vasopressin V2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL. Am J Physiol Renal Physiol 293: F1166-F1177, 2007
34. Giebisch G, Krapf R, Wagner C: Renal and extrarenal regulation of potassium. Kidney Int 72: 397-410, 2007